Genetics of Diabetes Studies - Kovler Diabetes Center

Archive

https://kovlerdiabetescenter.org/portfolio/trialnet-hydroxychloroquine-prevention/ About this Study TrialNet Hydroxychloroquine (HCQ) Prevention is a double-blinded, multicenter, randomized, placebo-controlled trial to determine whether treatment of participants with Stage 1 T1D (2 or more antibodies with normal glucose tolerance) with HCQ results in delay or prevention of progression to Stage 2 T1D (abnormal...

About the Study: These studies focus on the prevalence, complications of, and best treatments for monogenic diabetes (MODY and neonatal diabetes) through saliva and long-term data collection. Eligibility Criteria: Eligibility determination is made by study staff. Typical inclusion criteria include: diagnosis of diabetes at strong linear family history of...

About the RISE Study Are you overweight and worried about developing diabetes? Do you have a family history of diabetes? Has a health care provider ever spoken to you about high blood sugar?  Or said you have “borderline diabetes”? If you answered YES to any of these questions, then...

About this Study The Natural History Study of the Development of type 1 diabetes will study people at increased risk for type 1 diabetes to learn more about how type 1 diabetes occurs. TrialNet is screening close blood relatives of people with type 1 diabetes because relatives...